For research use only. Not for therapeutic Use.
Sonepcizumab (LT 1009) is a fully human anti-S1P monoclonal antibody. Sonepcizumab has the potential for the research of metastatic renal cell carcinoma (mRCC)[1].
| Catalog Number | I042403 |
| CAS Number | 1031360-18-5 |
| Purity | ≥95% |
| Reference | [1]. Pal SK, et al. A phase 2 study of the sphingosine-1-phosphate antibody sonepcizumab in patients with metastatic renal cell carcinoma. Cancer. 2017 Feb 15;123(4):576-582. |
